Related Experiment Video
Updated: Feb 3, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes-Bayesian Network Analysis.
Fernando Magro1,2,3, Cláudia Camila Dias4,5, Francisco Portela6
1Gastroenterology Department, Hospital São João, Porto, Portugal.
This study developed risk matrices to predict ulcerative colitis (UC) patients needing colectomy or facing progressive disease. These tools aid in personalizing treatment strategies for better patient outcomes.
Area of Science:
- Gastroenterology
- Clinical Epidemiology
- Predictive Analytics
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease with potentially severe symptoms.
- Colectomy (surgical intervention) is sometimes required for advanced UC cases.
- Predicting disease progression and the need for colectomy is crucial for patient management.
Purpose of the Study:
- To determine the risk factors associated with disease progression in UC patients.
- To identify patients at high risk of requiring colectomy.
- To develop predictive models for UC outcomes.
Main Methods:
- A multicentre study involving 1481 patients from a Portuguese inflammatory bowel disease database.
- Bayesian networks and logistic regression were employed to construct risk matrices.
- Internal and external validation of the predictive models was performed.
Main Results:
- The derivation cohort (1210 patients) showed 6% required colectomy and 37% experienced progressive disease over 12 years.
- High-risk factors for colectomy include prior hospitalization, extensive disease, lack of immunomodulators, and corticosteroid refractoriness (88% risk).
- High-risk factors for progressive disease include male gender, extensive disease, and age under 40 at diagnosis (72% risk).
Conclusions:
- Risk matrices accurately predict the likelihood of colectomy or progressive disease in UC patients.
- These predictive tools can facilitate individualized therapeutic strategies.
- The study provides valuable insights for managing ulcerative colitis and preventing severe outcomes.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Reliability and Validity
In Vitro Drug Release Testing: Overview, Development and Validation
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Predicting Reaction Outcomes

